176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
31.23%
Some net income increase while MRVL is negative at -633.64%. John Neff would see a short-term edge over the struggling competitor.
-2.09%
Negative yoy D&A while MRVL is 14.46%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
114.63%
Well above MRVL's 43.41% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
2.88%
Less SBC growth vs. MRVL's 55.90%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-831.03%
Both reduce yoy usage, with MRVL at -301.23%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-608.55%
Both yoy AR lines negative, with MRVL at -25.01%. Martin Whitman would suspect an overall sector lean approach or softer demand.
52.40%
Some inventory rise while MRVL is negative at -13901.04%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-6.67%
Both negative yoy AP, with MRVL at -1154.32%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-79.04%
Both reduce yoy usage, with MRVL at -616.95%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-700.00%
Negative yoy while MRVL is 129.41%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-9.34%
Both yoy CFO lines are negative, with MRVL at -108.67%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-5.30%
Both yoy lines negative, with MRVL at -9.21%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-94.12%
Negative yoy acquisition while MRVL stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
31.18%
Purchases growth of 31.18% while MRVL is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-4.22%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
94.12%
Less 'other investing' outflow yoy vs. MRVL's 223.82%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
59.35%
We have mild expansions while MRVL is negative at -15557.72%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
We repay more while MRVL is negative at -80.72%. John Neff notes advantage in lowering leverage if competitor is ramping up debt or repaying less.
No Data
No Data available this quarter, please select a different quarter.
-111.06%
Both yoy lines negative, with MRVL at -187.42%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.